NVDA Scenario Review: Patient, Scaled Long Into Earnings

Scenario Review
Public educational edition
NVDA · 2026-05-18

NVDA Scenario Review: Patient, Scaled Long Into Earnings

A staged NVDA long that refuses to chase spot, caps pre-print risk, and keeps the heavier size for either a better fade fill or the post-earnings confirmation window.

NVDA
Stance: Patient, scaled long into earnings

Bias / posture
Patient, scaled long into earnings

This is a conditional scenario map, not a blind conviction call.

Key levels
Structured map

$215 / $210 ladder · hard stop $193.97 · first target $250-$255 · next target $272.94

Trigger required
Confirmation matters

Keep pre-print size capped. Add heavier only on strong guide and margin confirmation, or after a clean post-earnings hold of .

What this review is doing

What matters, what confirms, what invalidates.

This CAMS scenario review translates the full NVDA memo into a public-facing research surface without pretending the market owes anyone a result. The goal is clarity: the posture, the trigger, the risk line, and the conditions that can still break the thesis.

  • What confirms: Keep pre-print size capped. Add heavier only on strong guide and margin confirmation, or after a clean post-earnings hold of .
  • What invalidates: Guide $85B or worse, gross margin 72% or worse, or a daily close below the 50-day SMA at $193.97.
  • What the full report adds: methodology, source traceability, and disclosure framing.
Inside the full report
  • Decision summary and position framing
  • Execution map and key risk markers
  • Three-lens methodology appendix
  • Source traceability appendix
  • Disclosure and distribution framing
Full report

Public educational edition

The full report is embedded below in a web-readable format so the research is actually readable on the site, not stranded in a local file or buried behind a tiny print cover.

Web reading mode

The embedded report starts on the decision summary instead of the print cover and table of contents so the first screen is actually readable on the live site.

Executive Decision

Decision Summary

Current decision
Buy (scaled, patient long; do not chase spot)

Confidence: Medium.   Time horizon: Primary holding window is 1-3 months through the 6/17 Warsh FOMC, with longer carry only if the fundamental thesis keeps paying. Time stop: if NVDA cannot reclaim and progress above $230 by 6/17, trim back to starter size and reassess.

Size
Total intended footprint = moderate core long at roughly 3.0% NAV equity plus roughly 0.5% NAV defined-risk premium. Pre-print working tranche is capped at roughly 1.0% NAV so the binary cannot blow up the book. The remaining equity size is reserved for either a $207-$215 fade fill or the post-print IV-crush re-entry window.
Order
Work a layered pre-print equity ladder only. Tranche 1: limit $215.00 for roughly 25% of the equity sleeve. Tranche 2: limit $210.00 for roughly 25% of the equity sleeve. No market buys near the $222.94 spot reference. Use a defined-risk options overlay only as hedge support around the 5/20 after-close print.
Stop
Hard stop on a daily close below $193.97, the 50-day SMA. This is the structural trend support and the regime-change line. Do not negotiate it and do not average down through it.
Primary target
$250-$255. Scale out one-third of the equity sleeve here. From the $215 first tranche this is roughly 1.7:1 reward to the $193.97 stop.
Secondary targets
$272.94 for the next one-third scale-out. Runner only above $300 on a clean beat-and-raise path with supportive macro and Rubin commentary. Trail the stop to entry once $255 prints.
Hedge / structure
Buy the June $200/$185 put spread for roughly 0.20% NAV premium as the pre-print downside hedge. The source memo explicitly flags this for pressure-testing because the short strike sits below the hard stop; if a better strike pair is available at acceptable cost, prefer the hedge that aligns more tightly with the stop zone.
Time horizon
Primary holding window is 1-3 months through the 6/17 Warsh FOMC, with longer carry only if the fundamental thesis keeps paying. Time stop: if NVDA cannot reclaim and progress above $230 by 6/17, trim back to starter size and reassess.
Trade Construction

Position Architecture

Action: Buy (scaled, patient long; do not chase spot) Size: Total intended footprint = moderate core long at roughly 3.0% NAV equity plus roughly 0.5% NAV defined-risk premium. Pre-print working tranche is capped at roughly 1.0% NAV so the binary cannot blow up the book. The remaining equity size is reserved for either a $207-$215 fade fill or the post-print IV-crush re-entry window. Order: Work a layered pre-print equity ladder only. Tranche 1: limit $215.00 for roughly 25% of the equity sleeve. Tranche 2: limit $210.00 for roughly 25% of the equity sleeve. No market buys near the $222.94 spot reference. Use a defined-risk options overlay only as hedge support around the 5/20 after-close print. Stop: Hard stop on a daily close below $193.97, the 50-day SMA. This is the structural trend support and the regime-change line. Do not negotiate it and do not average down through it. Primary target: $250-$255. Scale out one-third of the equity sleeve here. From the $215 first tranche this is roughly 1.7:1 reward to the $193.97 stop. Secondary targets: $272.94 for the next one-third scale-out. Runner only above $300 on a clean beat-and-raise path with supportive macro and Rubin commentary. Trail the stop to entry once $255 prints. Hedge: Buy the June $200/$185 put spread for roughly 0.20% NAV premium as the pre-print downside hedge. The source memo explicitly flags this for pressure-testing because the short strike sits below the hard stop; if a better strike pair is available at acceptable cost, prefer the hedge that aligns more tightly with the stop zone. Time horizon: Primary holding window is 1-3 months through the 6/17 Warsh FOMC, with longer carry only if the fundamental thesis keeps paying. Time stop: if NVDA cannot reclaim and progress above $230 by 6/17, trim back to starter size and reassess. Confidence: Medium.

Committee Synthesis

Risk Committee Read-Through

  • The source did not come with a separate multi-seat committee packet, so the usable committee read-through is the memo's own pressure-testing language.
  • I accepted the source's core discipline point: patience is the edge here, not chasing a $222.94 spot price two trading days before the binary.
  • I accepted the pre-print size cap because the memo explicitly frames this as a direction-bull but timing-bear setup with 30-day implied volatility above realized volatility.
  • I accepted the hard 50-SMA stop because the memo treats a close below $193.97 as structural failure, not ordinary noise.
  • I kept the hedge in the decision structure, but I preserved the source memo's warning that the proposed $200/$185 put spread does not line up perfectly with the stop location and should be challenged rather than treated as sacred.
Decision Logic

Decision Rationale

Why This Decision

The source memo's strongest point is that the right trade is not "buy NVDA now." The right trade is a staged long with patience, explicit binary sizing, and a larger post-print reserve. Spot is stretched above the 50-SMA after a failed-breakout outside-down day, so a blind market buy is the weak version of the thesis. The layered $215/$210 approach preserves the bull direction while respecting the timing problem the memo is built around.

The memo also makes the correct tradeoff on pre-print deployment: under-commit into the event, keep the bigger size for either a cleaner fade fill or the post-earnings IV-crush window, and refuse to convert a medium-conviction setup into a full-risk spot chase. That is why the decision stays constructive but deliberately patient.

Rules of Engagement

Path / Reversal Triggers

Path-Dependent Adjustments

  • If Q2 guide is at least $87B, gross margin is at least 74%, and Rubin commentary is constructive, add the heaviest weight on the first pullback after the open gap. Do not buy into the gap itself.
  • If guide is in-line at $85-$87B with gross margin around 73-74%, wait for NVDA to hold $215 on the 5/21 close before adding.
  • If guide misses, gross margin is 72% or lower, or Rubin commentary signals slippage, do not average down. Work the stop and reassess at the 50-SMA.
  • Once $255 prints, trail the remaining stop to entry.
  • If there is no progress above $230 by 6/17, cut the core back to starter size and reassess rather than letting time decay turn patience into drift.

What Could Reverse This Decision

  • Q2 guide of $85B or lower, or explicit Rubin slippage on the 5/20 call.
  • Gross margin guide of 72% or lower.
  • Daily close below the 50-day SMA at $193.97.
  • A House floor markup date for the AI OVERWATCH Act before 6/17.
  • A hawkish 6/17 Warsh dot-plot surprise that removes two cuts.
  • AVGO commentary in June confirming OpenAI, Anthropic, or Google TPU 2027 cadence at scale.
Portfolio Context

Book Notes and Methodology

Book Notes

Three source-driven cautions matter. First, the proposed $200/$185 put spread only fully pays after the hard-stop zone has already failed, so the hedge structure should be challenged for strike alignment rather than accepted by default. Second, if either pre-print limit fills on a sharp 5/19 selloff, the book could still be long into the print without an IV-crush cushion; the memo explicitly raises the possibility that the starter should be options-only until after earnings. Third, three of the prior four NVDA prints faded despite beats, so the post-print add must respect the possibility that the cleaner move is the second down day rather than the first gap reaction.

Methodology Guardrails

  • Source-bound generation: no unsupported facts are added.
  • Decision fields are extracted from bold labels in the Decision section when present.
  • Missing required sections fail strict preflight and must be repaired upstream.
  • Variant differences are distribution language and traceability depth, not changed investment conclusions.
Controlled Distribution

Disclosures

For informational and educational purposes only. Not investment advice, not a trade recommendation, and not a solicitation to buy or sell any security. Investing involves risk, including possible loss of principal. Consult your own financial, legal, and tax advisors.

Source Basis

Source basis: internal decision memo dated 2026-05-18

QA Status

  • No parser warnings.

Generated 2026-05-18T12:52:44-04:00.

Method
Three-lens review

CAMS uses a source-bound three-lens review: entry discipline, risk line, and scenario response. The public page keeps the setup readable without pretending certainty.

Discipline
Reaction over theater

The setup is only allowed to improve if confirmation actually prints. No confirmation, no fantasy sizing.

Disclosure
Public educational framing

CAMS content is for educational, informational, and entertainment purposes only. It is not personalized investment advice or a recommendation to buy, sell, or hold any financial instrument.

CAMS content is for educational, informational, and entertainment purposes only. It is not personalized investment advice or a recommendation to buy, sell, or hold any financial instrument.